[1] |
LaForce C, Journeay GE, Miller SD, et al. Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study[J]. Ann Allergy Asthma Immunol, 2013, 111(1):45-50.
doi: 10.1016/j.anai.2013.04.013
URL
|
[2] |
Liu A, Manche EE. Bilateral posterior subcapsular cataracts associated with long-term intranasal steroid use[J]. J Cataract Refract Surg, 2011, 37(8):1555-1558.
doi: 10.1016/j.jcrs.2011.05.020
URL
|
[3] |
Opatowsky I, Feldman RM, Gross R, et al. Intraocular pressure elevation associated with inhalation and nasal corticosteroids[J]. Ophthalmology, 1995, 102(2):177-179.
pmid: 7862403
|
[4] |
葛坚. 眼科学[M]. 北京: 人民卫生出版社, 2002:50.
|
[5] |
Kersey JP, Broadway DC. Corticosteroid-induced glaucoma: a review of the literature[J]. Eye (Lond), 2006, 20(4):407-416.
pmid: 15877093
|
[6] |
Bross-Soriano D, Hanenberg-Milver C, Schimelmitz-Idi J, et al. Effects of three nasal topical steroids in the intraocular pressure compartment[J]. Otolaryngol Head Neck Surg, 2004, 130(2):187-191.
doi: 10.1016/j.otohns.2003.09.020
URL
|
[7] |
Bergmann J, Witmer MT, Slonim CB. The relationship of intranasal steroids to intraocular pressure[J]. Curr Allergy Asthma Rep, 2009, 9(4):311-315.
doi: 10.1007/s11882-009-0044-z
URL
|
[8] |
Garbe E, LeLorier J, Boivin JF, et al. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma[J]. JAMA, 1997, 277(9):722-727.
doi: 10.1001/jama.1997.03540330044033
URL
|
[9] |
Oztürk F, Yücetürk AV, Kurt E, et al. Evaluation of intraocular pressure and cataract formation following the long-term use of nasal corticosteroids[J]. Ear Nose Throat J, 1998, 77(10):846-848,850-851.
doi: 10.1177/014556139807701012
URL
|
[10] |
Bui CM, Chen H, Shyr Y, et al. Discontinuing nasal steroids might lower intraocular pressure in glaucoma[J]. J Allergy Clin Immunol, 2005, 116(5):1042-1047.
doi: 10.1016/j.jaci.2005.07.031
URL
|
[11] |
Spiliotopoulos C, Mastronikolis NS, Petropoulos IK, et al. The effect of nasal steroid administration on intraocular pressure[J]. Ear Nose Throat J, 2007, 86(7):394-395.
doi: 10.1177/014556130708600714
URL
|
[12] |
Bousquet J, van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma[J]. J Allergy Clin Immunol, 2001, 108(5 Suppl):S147-S334.
|
[13] |
Clark AF, Wilson K, McCartney MD, et al. Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells[J]. Invest Ophthalmol Vis Sci, 1994, 35(1):281-294.
|
[14] |
Benninger MS, Ahmad N, Marple BF. The safety of intranasal steroids[J]. Otolaryngol Head Neck Surg, 2003, 129(6):739-750.
doi: 10.1016/j.otohns.2003.10.001
URL
|
[15] |
Yuen D, Buys YM, Jin YP, et al. Effect of beclomethasone nasal spray on intraocular pressure in ocular hypertension or controlled glaucoma[J]. J Glaucoma, 2013, 22(2):84-87.
doi: 10.1097/IJG.0b013e3182254811
URL
|
[16] |
Dreyer EB. Inhaled steroid use and glaucoma[J]. N Engl J Med, 1993, 329(24):1822.
|
[17] |
Man LX, Farhood Z, Luong A, et al. The effect of intranasal fluticasone propionate irrigations on salivary cortisol, intraocular pressure, and posterior subcapsular cataracts in postsurgical chronic rhinosinusitis patients[J]. Int Forum Allergy Rhinol, 2013, 3(12):953-957.
doi: 10.1002/alr.21228
URL
|
[18] |
Spiliotopoulos C, Mastronikolis NS, Petropoulos IK, et al. The effect of nasal steroid administration on intraocular pressure[J]. Ear Nose Throat J, 2007, 86(7):394-395.
doi: 10.1177/014556130708600714
URL
|